Company
El.En. SpA
Headquarters: Epalinges, Switzerland
Employees: 6
Market Cap
€4.7 Million
EUR as of July 1, 2023
US$5.1 Million
Switzerland
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
Zoetis Inc.
|
$78.54 B |
MERCK Kommanditgesellschaft auf Aktien
|
$70.69 B |
Takeda Pharmaceutical Company Limited
|
$46.59 B |
Haleon plc
|
$37.99 B |
|
Eisai Co. Ltd
|
$17.26 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$428.70 B |
|
Lilly
|
$417.05 B |
|
Johnson & Johnson
|
$412.24 B |
Novo Nordisk
|
$329.83 B |
|
Merck
|
$275.82 B |
Detailed Description
Elanix Biotechnologies AG, a tissue regeneration company, develops and commercializes products for acute wound care, dermatological, and gynecological applications, and provides cell technology services. It also owns cell banks containing various quantities of cells. The company was founded in 1966 and is headquartered in Epalinges, Switzerland.
Unlock the Power of Financial AI:
Try Disfold AI Free for 7 Days!
Stocks & Indices
El.En. SpA has the following listings and related stock indices.
Stock: FSX: ELN wb_incandescent